Skip to content

American Journal of Psychotherapy

ISSN 0002-9564

2 papers in the library · 281 citations · publishing 1986-2021

Papers

Can Drugs Be Used to Enhance the Psychotherapeutic Process?

American Journal of Psychotherapy July 1, 1986 Lester Grinspoon, James B. Bakalar 189 citations

Many preindustrial cultures used psychedelic plants to enhance practices resembling psychotherapy, an idea tested in Western psychiatry during the 1950s and 1960s. LSD and similar drugs were employed to facilitate memories, fantasies, and insights and to strengthen the therapeutic alliance, but results were inconclusive, and research largely ended when the drugs became hard to obtain. Revival of such research may now be possible with newer drugs that avoid some drawbacks of older ones. MDMA (3,4-methylenedioxymethamphetamine) is currently of most interest; it is relatively mild and short-acting, reportedly enhancing introspection and intimacy without the perceptual changes, emotional unpredictability, or adverse reactions linked to LSD.

Systematized Review of Psychotherapeutic Components of Psilocybin-Assisted Psychotherapy

American Journal of Psychotherapy July 23, 2021 David M. Horton, Blaise Morrison, Judy A. Schmidt 92 citations

A systematized review of clinical trials on psychedelic-assisted psychotherapy (PAP) published over the past 25 years found important commonalities among the studies but also revealed key differences in how psychotherapy was incorporated into PAP. The authors conclude that additional research is needed to identify the unique effect of psychotherapy in PAP.